
Cannacurio # 46: Georgia Announces License Winner
Be the first to know when new content like this is available!
Subscribe to our newsletter to receive notifications of new posts, local news and industry insights.
Thank you! Your submission has been received!
Oops! There was an error submitting the form.
Finally, the Georgia Access to Medical Marijuana Commission has selected six companies that are allowed to grow, manufacture, and sell medical marijuana oil with a 5% THC limit. Each license holder is allowed to open five pharmacies.
· Trulieve and Fine Fettle Dispensaries were the only MSOs to be licensed.
· Curaleaf, Verano, Columbia Care, Parallel / Surterra and Revolution did not win.
· At the same time, a recent investor deck referred to their home state advantage – will this loss be reflected in the IPO of their SPAC?
Botanical Sciences LLC and Trulieve GA, Inc. received Class 1 production licenses that allow for up to 100,000 square feet of growing space. Here are the applicants and their ratings with notable MSO losses in red font:
Copyright © 2021 by CNB Media LLC dba Cannabiz Media Source: Cannabiz Media License Database www.cannabiz.media
FFD GA Holdings (Fine Fettle Dispensary) Theratrue Georgia LLC, Natures GA LLC, and Treevana Remedy Inc. received a Class 2 license that allows them to grow cannabis within 50,000 square feet of coverage. As with the Class 1 license, there were plenty of MSOs that didn’t make the podium, including Curaleaf, Revolution Georgia, Verano, Columbia Care, and Parallel / Surterra – the hometown favorite.
Copyright © 2021 by CNB Media LLC dba Cannabiz Media Source: Cannabiz Media License Database www.cannabiz.media
According to the Atlanta Journal constitution, the next steps in the medical marijuana program will be to sign contracts with the six winning companies and then start operations next year. Companies have one year to start operations after signing the contract after possible protests against lost bidders.
Now the lawsuits begin. Hopefully the process won’t drag on too long as patients in this state have been waiting for years to get access to this drug without having to import it across borders.
Ed Keating is the co-founder of Cannabiz Media and oversees the company’s data research and government relations efforts. He has spent his career working with and advising information companies on compliance issues. Ed has led product, marketing and sales while overseeing complex multi-jurisdiction product lines in the securities, corporate, UCC, security, environmental and human resource markets.
At Cannabiz Media, Ed enjoys the challenge of working with regulators around the world as he and his team collect corporate, financial, and licensing information to keep track of the people, products, and companies in the cannabis industry.
Ed graduated from Hamilton College and received his MBA from Northwestern University’s Kellogg School.
Cannabiz Media customers can keep up to date on these and other new licenses through our newsletter, warning and reporting modules. Subscribe to our newsletter to receive these weekly reports in your inbox. Or you can schedule a demo for more information on how you can access the Cannabiz media license database yourself to examine this data in more detail.
Cannacurio is a weekly column from Cannabiz Media with insights from the most comprehensive license data platform. Check out Cannacurio posts and podcasts for the latest updates and information.
Post a comment: